Close Menu

NEW YORK (GenomeWeb) – OpGen announced today it has partnered with the New York State Department of Health and Ilúm Health Solutions, a subsidiary of Merck's Healthcare Services and Solutions, to build an antimicrobial resistance tracking tool for the state healthcare system.

OpGen will receive a $1.5 million contract for a 12-month demonstration portion of the project, according to a statement, with potential for full implementation during the next five years, depending on meeting certain milestones. Further terms of the partnership were not disclosed

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.